<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref17">
 <label>17</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zheng</surname>
    <given-names>SQ</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>PX</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>HB</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>RS</given-names>
   </name>
  </person-group>
  <article-title>Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective</article-title>
  <source>Res Social Adm Pharm</source>
  <year>2020</year>
  <month>3</month>
  <day>26</day>
  <comment>
   <ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/32249102" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  </comment>
  <pub-id pub-id-type="doi">10.1016/j.sapharm.2020.03.012</pub-id>
  <pub-id pub-id-type="medline">32249102</pub-id>
  <!--<pub-id pub-id-type="pii">S1551-7411(20)30284-9</pub-id>-->
  <!--<pub-id pub-id-type="pmcid">PMC7102520</pub-id>-->
 </element-citation>
</ref>
